AI Summary
- Pharmaceutical industry made substantial and persistent payments to Australian psychiatrists over nine years, with an overall upward trend.
- Payments were highly concentrated among a small group of psychiatrists and a few pharmaceutical companies.
- Findings highlight potential conflicts of interest and support stronger transparency and policy measures to manage industry influence in psychiatric practice.
Aust N Z J Psychiatry. 2026 Nov 1:48674261502664. doi: 10.1177/00048674261502664. Online ahead of print.
NO ABSTRACT
PMID:42967901 | DOI:10.1177/00048674261502664
Share Evidence Blueprint
Save to Google Notes
Search Google Scholar
Save as PDF
⭐ My Revision List
